Chemical constituents of Swertia yunnanensis and their anti-hepatitis B virus activity

被引:26
|
作者
Cao, Tuan-Wu [1 ,2 ]
Geng, Chang-An [1 ]
Jiang, Fu-Qiang [1 ]
Ma, Yun-Bao [1 ]
He, Kang [1 ]
Zhou, Ning-Jia [1 ,2 ]
Zhang, Xue-Mei [1 ]
Zhou, Jun [1 ]
Chen, Ji-Jun [1 ]
机构
[1] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100039, Peoples R China
基金
中国科学院西部之光基金; 美国国家科学基金会; 中国国家自然科学基金;
关键词
Swertia yunnanensis; Gentianaceae; Triterpenoids; Sweriyunnanosides A-C; Anti-HBV activity; PENTACYCLIC TRITERPENOIDS;
D O I
10.1016/j.fitote.2013.05.023
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Four new triterpenoids, sweriyunnangenin A (1), sweriyunnanosides A (2), B (3) and C (4), along with nineteen known compounds (5-23) were isolated from Swertia yunnanensis. Based on extensive spectroscopic analyses (1D- and 2D-NMR, HRESIMS, UV, IR, [alpha](D)), the structures of sweriyunnangenin A (1), sweriyunnanosides A (2), B (3) and C (4) were elucidated as taraxer-14-ene-3 alpha,6 beta-diol, oleanolic acid 28-O-beta-D-glucopyranosyl-(1 -> 2)-O-beta-D-glucopyranoside, 2 alpha,3 beta-di-hydroxyolean-12-en-28-oic acid 28-O-beta-D-glucopyranosyl(1 -> 6)-beta-D-glucopyranosyl (1 -> 6)-beta-D-glucopyranosyl(1 -> 2)-beta-D-glucopyranoside and hederagenin 28-O-beta-D-glucopyranosyl (1 -> 6)-beta-D-glucopyranosyl(1 -> 6)-beta-D-glucopyranosyl(1 -> 2)-beta-D-glucopyranoside, respectively. Twenty-two compounds were evaluated for their anti-HBV activities on the HepG 2.2.15 cell line in vitro, of which nine compounds showed potent anti-HBV activities. Compounds 1, 5-6, 14-16 and 19 showed activities against the secretion of HBsAg (IC50 values from 0.10 to 1.76 mM) and HBeAg (IC50 values from 0.04 to 1.41 mM), and compounds 11 and 13-16 exhibited significant inhibition on HBV DNA replication (IC50 values from 0.01 to 0.09 mM). (c) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 50 条
  • [41] Synthesis and anti-hepatitis B virus activity of glucosylated 2-O-ethyluracils
    Abdel-Rahman, AAH
    MONATSHEFTE FUR CHEMIE, 2003, 134 (06): : 929 - 939
  • [42] Nucleotide analogs as novel anti-hepatitis B virus agents
    Iyer, RP
    Padmanabhan, S
    Zhang, GR
    Morrey, JD
    Korba, BE
    CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (05) : 520 - 528
  • [43] An overview of anti-Hepatitis B virus flavonoids and their mechanisms of action
    Naderi, Malihe
    Salavatiha, Zahra
    Gogoi, Urvashee
    Mohebbi, Alireza
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [44] Panaxadiol and Panaxatriol Derivatives as Anti-Hepatitis B Virus Inhibitors
    Chen H.
    Wang L.-J.
    Ma Y.-B.
    Huang X.-Y.
    Geng C.-A.
    Zhang X.-M.
    Chen J.-J.
    Natural Products and Bioprospecting, 2014, 4 (3) : 163 - 174
  • [45] Advantages of RNA interference in anti-hepatitis B virus therapy
    Zhang Xue-Zhi
    Shan Chang-Liang
    Ye Li-Hong
    Zhang Xiao-Dong
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2008, 35 (06) : 631 - 636
  • [46] Anti-Hepatitis B Virus Drugs in Clinical and Preclinical Development
    Gui-feng WANG1
    2. Laboratory of Immunology and Virology
    Virologica Sinica, 2008, (02) : 137 - 145
  • [47] Liver mechanosignaling as a natural anti-hepatitis B virus mechanism
    Ye, Jianyu
    Li, Fahong
    Hua, Ting
    Ma, Kewei
    Wang, Jinyu
    Zhao, Zixin
    Yang, Zhongning
    Luo, Chen
    Jia, Ruohan
    Li, Yaming
    Hao, Menghan
    Wu, Jian
    Lu, Mengji
    Yuan, Zhenghong
    Zhang, Jiming
    Chen, Jieliang
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [48] Seroprevalence of Hepatitis B Surface Antigen, Anti-Hepatitis B Surface and Anti-Hepatitis C Virus Among Pregnant Women Residing in Sirnak Province
    Sahin, Meyha
    Zencir, Meltem
    Gozubuyuk, Alper Akin
    Pektas, Bedri Aras
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2018, 24 (01): : 7 - 11
  • [49] No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity
    Haushofer, AC
    Hauer, R
    Brunner, H
    Köller, U
    Trubert-Exinger, D
    Halbmayer, WM
    Koidl, C
    Kessler, HH
    JOURNAL OF CLINICAL VIROLOGY, 2004, 29 (04) : 221 - 223
  • [50] Hepatitis flares and hepatitis B e antigen seroconversion: Implication in anti-hepatitis B virus therapy
    Liaw, YF
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (03) : 246 - 252